Press Releases Catalent, Inc.

Equities

CTLT

US1488061029

Market Closed - Nyse Other stock markets 21:00:01 26/04/2024 BST			5-day change	1st Jan Change
55.92 ^USD	+0.22%		+0.79%	+24.46%

04-12	Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48	MT
04-08	Sector Update: Health Care Stocks Decline Late Afternoon	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)	04-18	BU
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer	03-13	AQ
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, ZFOX	03-12	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	03-12	PR
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment	03-07	BU
Catalent : Change in Certifying Accountants - Form 8-K	03-01	PU
Catalent : Publishes Fifth Annual Corporate Responsibility Report	03-01	PU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	02-24	PR
CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT	02-16	BU
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, AXNX, BATL, APA	02-16	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT	02-15	PR
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results	02-12	AQ
Catalent: Fiscal Q2 Earnings Snapshot	02-09	AQ
Catalent, Inc. Reports Second Quarter Fiscal 2024 Results	02-09	BU
CTLT Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Catalent, Inc. for Potential Securities Law Violations	02-07	AQ
Novo Nordisk $11b acquisition to support manufacturing capacity	02-05	AQ
CTLT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Catalent to Novo Holdings	02-05	AQ
Shareholder Alert: Ademi LLP investigates whether Catalent, Inc. has obtained a Fair Price in its transaction with Novo Holdings	02-05	PR
SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Catalent; Is $63.50 a Fair Price?	02-05	BU
CTLT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Catalent, Inc. Is Fair to Shareholders	02-05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Catalent, Inc.

Equities

CTLT

US1488061029

Press Releases

Filters